DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Letairis (Ambrisentan) - Pulmonary Oedema - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pulmonary Oedema ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Letairis (Ambrisentan) where reactions include pulmonary oedema. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Letairis side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male

Reactions: Dyspnoea, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female

Reactions: Pulmonary Vein Stenosis, Pulmonary Oedema, Unevaluable Event, Fluid Retention, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Letairis
    Indication: Heart Disease Congenital

Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2012-06-11

Letairis
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Trisomy 21
    Start date: 2012-06-28

Letairis
    Indication: Sleep Apnoea Syndrome

Letairis
    Indication: Pulmonary Vein Stenosis



Possible Letairis side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female

Reactions: Pulmonary Oedema, Cardiac Disorder, Fluid Retention

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: female

Reactions: Oedema Peripheral, Compression Fracture, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient: male

Reactions: Dyspnoea, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: female

Reactions: Pulmonary Vein Stenosis, Pulmonary Oedema, Unevaluable Event, Oxygen Saturation Decreased, Fluid Retention

Drug(s) suspected as cause:
Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2012-06-11

Letairis
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Trisomy 21
    Start date: 2012-06-28

Letairis
    Indication: Heart Disease Congenital

Letairis
    Indication: Pulmonary Vein Stenosis

Letairis
    Indication: Sleep Apnoea Syndrome



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: female

Reactions: Pulmonary Oedema, Fluid Retention, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Letairis
    Indication: Pulmonary Vein Stenosis

Letairis
    Indication: Trisomy 21

Letairis
    Indication: Sleep Apnoea Syndrome

Letairis
    Indication: Heart Disease Congenital

Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2012-06-11



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient: female

Reactions: Anaemia, Pulmonary Oedema, Renal Failure Acute, Cardiorenal Syndrome

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Letairis

Other drugs received by patient: Alphagan P; Acetaminophen; Stalevo 100; Multi-Vitamins; Gabapentin; Cellcept; Pantoprazole Sodium; Prednisone; Tums / 00193601 /; Lantus; Metoclopramide Hydrochloride; Citalopram Hydrobromide; Prograf; Aspirin; Docusate Sodium; Humalog; Reglan; Magnesium Gluconate; Xalatan; Furosemide



Possible Letairis side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female

Reactions: Pulmonary Oedema, Fluid Retention, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Letairis
    Indication: Heart Disease Congenital

Letairis
    Indication: Pulmonary Vein Stenosis

Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2012-06-11

Letairis
    Indication: Trisomy 21

Letairis
    Indication: Sleep Apnoea Syndrome



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-19

Patient: female

Reactions: Compression Fracture, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: female

Reactions: Pneumonia, Pulmonary Oedema, Unevaluable Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-29

Patient: female

Reactions: Anaemia, Pulmonary Oedema, Renal Failure Acute, Cardiorenal Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a physician from United States on 2012-05-24

Patient: female

Reactions: Anaemia, Pulmonary Oedema, Renal Failure Acute, Cardiorenal Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in

Reported by a physician from United States on 2012-05-18

Patient:

Reactions: Pruritus, Dysphagia, Nausea, Oropharyngeal Pain, Headache, Flushing, Sensation of Foreign Body, Throat Irritation, Pulmonary Oedema

Drug(s) suspected as cause:
Letairis

Ventavis
    Dosage: unk
    Indication: Pulmonary Arterial Hypertension
    Start date: 2012-04-12

Other drugs received by patient: Calcium Channel Blockers; ACE Inhibitors



Possible Letairis side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-07

Patient: female

Reactions: Coronary Artery Disease, Pulmonary Oedema

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-30

Patient: female

Reactions: Pulmonary Hypertension, COR Pulmonale Acute, Dyspnoea, Pulmonary Veno-Occlusive Disease, Pulmonary Oedema, Hypoxia, Respiratory Distress

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis
    Indication: Diastolic Dysfunction

Letairis
    Indication: Venoocclusive Disease

Letairis
    Indication: Pulmonary Arterial Pressure Increased

Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2012-02-22



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-19

Patient: female

Reactions: Vomiting, Nausea, Chest Pain, Pulmonary Oedema, Unevaluable Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-17

Patient: female

Reactions: Renal Failure, Pulmonary Oedema, Cardiac Failure Congestive, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-04

Patient: male

Reactions: Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a physician from United States on 2012-03-27

Patient: female

Reactions: Dyspnoea, Pulmonary Oedema, Pulmonary Arterial Hypertension, Pulmonary Function Test Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2011-03-20

Letairis
    Dosage: unk
    Administration route: Oral
    Indication: Connective Tissue Disorder

Remodulin

Other drugs received by patient: Revatio



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: female

Reactions: Dyspnoea, Pulmonary Oedema, Pulmonary Arterial Hypertension, Pulmonary Function Test Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2011-03-20

Letairis
    Dosage: unk
    Administration route: Oral
    Indication: Connective Tissue Disorder

Other drugs received by patient: Remodulin; Revatio



Possible Letairis side effects in male

Reported by a physician from United States on 2012-03-21

Patient: male

Reactions: Dialysis, Pulmonary Oedema, Unevaluable Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2012-01-26

Letairis
    Indication: Sleep Apnoea Syndrome

Letairis
    Indication: Collagen-Vascular Disease



Possible Letairis side effects in

Reported by a pharmacist from United States on 2012-03-21

Patient:

Reactions: Fluid Overload, Chest Discomfort, Dyspnoea, Dilatation Ventricular, Condition Aggravated, Hyperdynamic Left Ventricle, Pericardial Effusion, Cardiomegaly, Death, Right Atrial Dilatation, Brain Natriuretic Peptide Increased, Oedema Peripheral, Oedema, Pulmonary Oedema, Pulmonary Artery Dilatation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Epoprostenol Sodium
    Dosage: 32 ng/kg, per min

Epoprostenol Sodium
    Dosage: 39 ng/kg, per min
    End date: 2012-03-12

Epoprostenol Sodium
    Dosage: 29 ng/kg, per min
    Indication: Pulmonary Arterial Hypertension
    Start date: 2010-12-24

Letairis

Other drugs received by patient: Bumex; Midodrine Hydrochloride; Aranesp



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: female

Reactions: Dyspnoea, Pulmonary Oedema, Pulmonary Function Test Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2011-03-20

Letairis
    Dosage: unk
    Administration route: Oral
    Indication: Connective Tissue Disorder

Other drugs received by patient: Remodulin; Revatio



Possible Letairis side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-03-07

Patient: 56 year old female

Reactions: Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis

Other drugs received by patient: Revatio; Remodulin



Possible Letairis side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-02-28

Patient: 56 year old female

Reactions: Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis

Other drugs received by patient: Remodulin; Revatio



Possible Letairis side effects in 75 year old female

Reported by a pharmacist from United States on 2012-01-30

Patient: 75 year old female

Reactions: Swelling, Pulmonary Oedema, Oedema, Fluid Retention

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-19

Patient: female

Reactions: Pulmonary Oedema, Pericardial Effusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis



Possible Letairis side effects in female

Reported by a physician from United States on 2011-12-19

Patient: female

Reactions: Pneumonia, Dyspnoea, Pulmonary Arterial Hypertension, Pulmonary Oedema, Oxygen Supplementation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis

Other drugs received by patient: Lasix; Oxygen; Iloprost; Sildenafil



Possible Letairis side effects in female

Reported by a pharmacist from United States on 2011-12-13

Patient: female

Reactions: Pneumonia, Dyspnoea, Pulmonary Oedema, Pulmonary Arterial Hypertension, Oxygen Supplementation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Letairis

Other drugs received by patient: Sildenafil; Lasix; Iloprost; Oxygen



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012